DuPont Mobility & Materials said it plans to invest $5 million in capital and operating resources at its plants in Germany and Switzerland to increase capacity for its high-performance automotive adhesives.
Fernando J. Gómez, head of the Chemical and Advanced Materials Industry at the World Economic Forum (WEF), discusses the chemical-industry-related topics that are high on the WEF’s agenda.
Yiğitoğlu, the family-run Turkish chemical manufacturing, distribution and logistics services group that started commercial activities in 1956, has set out to expand its geographic footprint.
Medical technology company Becton, Dickinson (BD) has revealed plans to build a fourth manufacturing plant in Spain. Investment costs are put at €165 million. Construction is scheduled to start in late 2021, and the plant will start up in 2023.
US engineering and construction group KBR and US-based multinational Cummins, a manufacturer of engines, filtration and power generation products, have agreed a non-exclusive partnership on green ammonia.
A US federal appeals court has upheld a $25 million jury award for the plaintiff in one of three major court battles Bayer has fought and lost over claims linking Monsanto’s glyphosate-based Roundup herbicide to non-Hodgkin lymphoma.
French firm Global Bioenergies has announced major progress in scaling up its new two-stage isobutene bio-production process, which it has been developing over the past few months.
French specialty chemicals producer Arkema said it plans to acquire Edge Adhesives Texas, as “a complementary asset” that will boost subsidiary Bostik’s offerings in high performance adhesives in the US. Financial terms were not disclosed.
The G 20 global health summit to be held in Rome, Italy, on May 21 is expected to commit to fund the distribution of Covid-19 vaccines and drugs to poorer countries, in an effort to make prevention and treatment of the coronavirus accessible for poorer nations. Press reports said, however, the original language of the commitment had been watered down from a more ambitious plan to commit to “fair and full financing.”
Dutch specialty chemicals and ingredients distributor IMCD has announced two acquisitions that boost its presence in the Latin American market.
US biotech Ginkgo Bioworks has entered into an agreement to buy Dutch DNA Biotech. Ginkgo said the move will expand its operations internationally for the first time. Financial terms of the deal, which is expected to close in July, were not disclosed.
US president Joe Biden announced this week that his administration will send an additional 20 million Covid-19 vaccine doses abroad by the end of June, this time including some approved for use in the US.
French CDMO Novasep is expanding its manufacturing capabilities for highly potent active pharmaceutical ingredients (HPAPIs) at its Le Mans site. The investment of more than €4 million will also create 30 new jobs at the site. It did not say when the expanded capabilities would be available.
As a step toward meeting the targets of its One Planet roadmap and at the same time contribute to China’s carbon neutrality goals, Solvay has reached agreement with Engie China to build its first solar power plant at its Zhenjiang site. The facility due to start up in April 2022 will have solar power capacity of 891 kw and is expected to cut emissions by 550 t of CO2 equivalent annually.
After seeing encouraging results with their adjuvanted recombinant Covid-19 vaccine candidate across all adult age groups in a recently completed Phase 2 trial, Sanofi and GlaxoSmithKline (GSK) are preparing to launch a global Phase 3 randomized double-blind study “in the coming weeks.”
Dutch life science ingredients distributor Barentz has opened an office in Buenos Aires, Argentina, expanding its coverage in Latin America. The move coincides with the appointment of subsidiary Barentz Argentina as a strategic partner of Roquette Freres for all of its human nutrition and pharmaceutical ingredients business in the country.
Ercros has announced plans to invest €40.4 million at its Tarragona site as part of its 3D strategic plan. The company added, however, that the sum could exceed €65 million, if other investments that are underway or pending authorization are included.
Problems at CDMO Emergent BioSolutions in the US state of Maryland and the resulting Food and Drug Administration shutdown of its Baltimore vaccine production facility continue to cloud the rollout of Johnson & Johnson’s Covid-19 shot. The newspaper Washington Post said the US federal government will not send any supplies of the healthcare group’s single-dose vaccine to states over the coming week, citing the weekly shipment allocation of the Centers for Disease Control (CDC).
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
How to Build or Maintain Critical Mass in the Chemical Distribution Industry
Analysis of the mergers & acquisitions activity in chemical distribution under the impression of the pandemic situation and how it might develop going forward.
Danish coatings company Hempel has agreed to buy Farrow & Ball, a UK luxury decorative paints company, from US-based private equity owners Ares Management. Financial terms were not disclosed.
After German Covid-19 vaccine maufacturer BioNTech announced earlier this week that it plans to expand into Asia with a new plant in Singapore, news has emerged that US rival Moderna will set up a production base in South Korea. The company has not yet confirmed a story by the Korea Times that quotes Korean government officials as sources.
A Mexican court has reversed a ruling that favored Bayer in a legal challenge brought by the German pharmaceuticals and agrochemicals group against Mexico’s plan to ban glyphosate. In a statement, the country’s Ministry of Environment and Natural Resources said the Collegiate Court had revoked the provisional suspension of plans to prohibit use of the chemical, of which Bayer is a leading producer.
US biotech Novavax has again delayed filing for approval of its protein-based Covid-19 vaccine at least until July this year, citing issues related to an assay needed to show that its manufacturing process is consistent across different sites. CEO Stanley Erck said the company now aims to submit data to regulators in the UK, US and EU in the third quarter of 2021 rather than in the second quarter as previously planned. The vaccine is currently in a rolling review with the European Medicines Agency (EMA).
In a nutshell, reaching sustainability has become a key aspect for chemical companies and adjacent businesses along the product chain with a high entry hurdle for everyone.
Croda International has announced it is undertaking a strategic review of its Performance Technologies and Industrial Chemicals (PTIC) businesses. The primary aim, said the UK specialty chemicals company, will be to establish what type of ownership structure best serves the businesses going forward and create a stronger platform for its future growth.
